University of Kentucky
Open enrollment with an early-phase pipeline tilt
According to ClinicalTrials.gov-derived indexes, University of Kentucky sits in the top decile of US sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count).
University of Kentucky: 54 sponsored US clinical trials, 5 recruiting.
University of Kentucky sponsors 54 registered US clinical trials on ClinicalTrials.gov, 5 of them currently recruiting, and 41 completed. 4 of these trials are in Phase 3-4 (later-stage) and 16 in Phase 1-2 (earlier-stage). The most-studied condition in this pipeline is Methamphetamine Abuse, with 2 trials.
Top-decile sponsor footprint
University of Kentucky ranks in the top decile of sponsors by registered trial count (#351 of 15,742 sponsors by registered trial count). Volume at this scale usually reflects a long institutional pipeline, read phase tilt and therapeutic areas below before treating it as current-year activity.
Trial completion reliability score
41 of 47 decided trials (Completed vs. Terminated on ClinicalTrials.gov) reached their planned completion (87.2%), vs. national p10 68.4% / p90 100% among 1,234 sponsors with at least 10 decided trials. Still-open trials (Recruiting, Active-not-recruiting, Not-yet-recruiting) are excluded since they have not reached an outcome yet.
Open and recent trials
54 total, page 2 of 2
Oral Infections: Dietary Regulation of Local and Systemic Inflammatory Responses
NCT00632957
Impact of a Psychological Biofeedback-Relaxation Intervention on Clinical, Physical and Psychological Outcomes in Patients With Heart Failure
NCT00255931
Phase I Using Velcade & Idarubicin in Elderly and Relapsed AML
NCT00382954
Phase I/II Study of Escalating-Dose Melphalan w/Autologous SCS & Amifostine Cytoprotect
NCT00003425
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 14 |
| Phase 2 | 2 |
| Phase 3 | 2 |
| Phase 4 | 2 |
Therapeutic Areas
What is open in the University of Kentucky pipeline
5 recruiting of 54 indexed (9% open); 41 completed (76%).
Phase mix: 4 late (III/IV) vs 16 early (I/II) (early-phase heavy).
Top condition: Methamphetamine Abuse (2 trials), 9 others listed.
How open-pipeline share is computed
Recruiting share is recruiting_count divided by trial_count for this sponsor in the public registry export. Status can change between pulls; treat the figure as a research-attention snapshot, not product availability.
University of Kentucky: open-pipeline peers nationwide
Peers matched on 54 registered trials and 9% open enrollment, not the therapeutic-area sidebar.
University of Kentucky sits at or above the median trial volume and at or above the median recruiting share among these 9 nationwide peers -- the two do not always move together.
Sponsors near 54 trials (± recruiting share)
- AdventHealth Translational Research Institute · 54 trials · 24% recruiting
- Auburn University · 54 trials · 24% recruiting
- Brooke Army Medical Center · 54 trials · 11% recruiting
- Corcept Therapeutics · 54 trials · 11% recruiting
Sponsors near 9% open enrollment (± trial volume)
- Shionogi · 9% recruiting · 54 trials
- University of Vermont · 9% recruiting · 162 trials
- Eli Lilly and Company · 9% recruiting · 1,341 trials
- Lahey Clinic · 9% recruiting · 43 trials
Related
What to do with this University of Kentucky page
54 registered trials is a research-attention snapshot, not an endorsement of University of Kentucky or any single study.
- 5 of University of Kentucky's trials are currently recruiting, check each one's own eligibility criteria before contacting a site. Browse recruiting trials
- Methamphetamine Abuse is the condition University of Kentucky studies most, compare against other sponsors active in the same condition before evaluating a specific study. See Methamphetamine Abuse trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. University of Kentucky pipeline card: 54 registered trials from official public datasets. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.